AKERO THERAPEUTICS INC. - COMMON STOCK
46.36
23-5月-25 13:45:00
15 分の遅延
株式
-2.61
-5.33%
本日の幅
45.58 - 48.50
ISIN
N/A
ソース
NASDAQ
-
10 11 2023 05:57:33 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics to Present at Upcoming Healthcare Conferences in November
08 11 2023 04:00:01 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics to Present at the H.C. Wainwright 7th Annual NASH Virtual Investor Conference
17 10 2023 13:05:00 提供 Nasdaq GlobeNewswire
-
10 10 2023 04:00:00 提供 Nasdaq GlobeNewswire
-
09 10 2023 13:05:00 提供 Nasdaq GlobeNewswire
-
04 10 2023 05:00:00 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics to Present at Upcoming Healthcare Conferences in September
31 8 2023 04:00:00 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics to Report Results of Phase 2b SYMMETRY Study in October 2023
28 8 2023 04:00:00 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
11 8 2023 03:00:00 提供 Nasdaq GlobeNewswire
-
01 6 2023 13:05:00 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics to Present at the Jefferies Healthcare Conference
31 5 2023 05:00:01 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics Announces Pricing of $220.0 Million Underwritten Offering of Common Stock
16 5 2023 15:53:36 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
15 5 2023 04:00:00 提供 Nasdaq GlobeNewswire
-
29 3 2023 13:01:00 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
17 3 2023 04:00:00 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics Appoints Patrick Lamy as Senior Vice President, Commercial Strategy
10 1 2023 05:00:01 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
04 1 2023 05:00:01 提供 Nasdaq GlobeNewswire
-
21 12 2022 13:01:00 提供 Nasdaq GlobeNewswire